​"Adoptive cell therapy for cancer treatment Market: Global Industry Analysis and Opportunity Assessment 2017-2027"

Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn’t true for all cancers.

A protein called FGL1 is a major inhibitory signal that blocks the immune system from fighting certain cancers, a team led by researchers at Yale Cancer Center (YCC) found.

The efficacy and safety observed with the CAR T-cell product bb21217 could help physicians get patients with heavily pretreated relapsed/refractory multiple myeloma on the path towards a cure, according to Nina Shah, MD.

A pivotal Phase 3 clinical trial testing a combination of Cabometyx (cabozantinib) with Tecentriq (atezolizumab) versus standard care of Nevaxar (sorafenib) in previously untreated patients with advanced hepatocellular carcinoma (HCC) — the most common ty

Due to the significant decline in smoking and an increase in advances for early cancer detection and screening, the cancer death rate has declined 27% in the United States from 1991 to 2016, according to the American Cancer Society’s annual report on canc